UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 729, 2023

SCIENCE 37 HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-39727

84-4278203

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)


800 Park Offices Drive, Suite 3606 Research Triangle Park, NC						27709
(Address of principal executive offices)						(Zip Code)

(984) 377-3737

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which

registered

Shares of Common stock, par value $0.0001 per share

SNCE

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 25.0207 ~~Results~~Submission of ~~Operations~~Matters ~~and~~to ~~Financial~~a ~~Condition~~Vote of Security Holders.

On November 729, 2023, Science 37 Holdings, Inc. (the “Company”) ~~issued~~held aits ~~press~~Special ~~release~~Meeting ~~announcing~~of Stockholders (the ~~Company’s~~“Special ~~financial~~Meeting”). ~~results~~Set ~~for~~forth ~~the~~below ~~third~~is ~~quarter~~the ~~ended~~matter ~~September~~acted ~~30,~~upon ~~2023.~~at Athe ~~copy~~Special ofMeeting and the ~~press~~final ~~release~~voting isresults ~~furnished~~on assuch ~~Exhibit~~matter, ~~99.1~~which towas ~~this~~described ~~Current~~in ~~Report~~the onCompany's ~~Form~~Definitive ~~8-K~~Proxy Statement filed with the Securities and isExchange ~~incorporated~~Commission ~~herein~~on byOctober ~~reference.~~27, 2023.

~~The~~Proposal ~~information~~One: inApproval ~~this~~of ~~Item~~an ~~2.02~~amendment ofto ~~this~~the ~~Current~~Second ~~Report~~Amended onand ~~Form~~Restated ~~8-K~~Certificate ~~(including~~of ~~Exhibit~~Incorporation ~~99.1)~~to iseffect, ~~furnished~~at ~~and~~the ~~not~~discretion ~~filed~~of ~~pursuant~~the toCompany's ~~Instruction~~Board ~~B.2~~ of ~~Form~~Directors, ~~8-K~~a ~~and~~reverse ~~shall~~stock split at a ratio not beless ~~deemed~~than ~~incorporated~~1-for-5 byand ~~reference~~not ingreater ~~any~~than ~~filing~~1-for-30, ~~under~~with the ~~Securities~~exact ~~Act~~ratio ofto ~~1933,~~be asset ~~amended,~~within orthat ~~the~~range ~~Exchange~~at ~~Act~~the discretion of ~~1934,~~the asCompany's ~~amended,~~Board ~~except~~of asDirectors ~~expressly~~without ~~set~~further ~~forth~~approval byor ~~specific~~authorization ~~reference~~of inthe ~~such filing.~~Company's stockholders.

~~Item~~ The ~~9.01 Financial~~Company’s ~~Statement~~stockholders approved an amendment to the Company’s Second Amended and ~~Exhibits~~Restated Certificate of Incorporation to effect, at the discretion of the Company's Board of Directors, a reverse stock split at a ratio not less than 1-for-5 and not greater than 1-for-30, with the exact ratio to be set within that range at the discretion of the Company's Board of Directors without further approval or authorization of the Company's stockholders. The results of the vote were as follows:

(d) Exhibits.



For		Against	Abstain	Broker Non-Votes
	79,727,311	1,239,022	33,156		—

Exhibit Number						Description
99.1						Press release dated November 7, 2023
104						Cover Page Interactive Data File (formatted as inline XBRL).

Proposal Two: Adjournment Proposal

Because the Company’s stockholders approved Proposal 1, a proposal to adjourn or postpone the meeting for the purpose of soliciting additional proxies (Proposal 2) was not voted upon at the Special Meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		Science 37 Holdings, Inc.
Date:	November 729, 2023	By:	/s/ ~~Mike~~Christine ~~Zaranek~~Pellizzari
		Name:	~~Mike~~Christine ~~Zaranek~~Pellizzari
		Title:	Chief ~~Financial~~Legal and Human Resources Officer

Filing Compare · Science 37 Holdings, Inc.